456 related articles for article (PubMed ID: 25933380)
21. The role of the tumor suppressor RUNX3 in giant cell tumor of the bone.
Han YX; Liang DY
Int J Oncol; 2012 Mar; 40(3):673-8. PubMed ID: 22076387
[TBL] [Abstract][Full Text] [Related]
22. Denosumab Induces Neoplastic Stromal Cell Apoptosis
Chen X; Ye F; He H; Chen G; Chen Z; Ye E; He B; Yang Y; Zhang J
Curr Cancer Drug Targets; 2024; 24(5):565-578. PubMed ID: 37961860
[TBL] [Abstract][Full Text] [Related]
23. Specific functional pathologies of Cx43 mutations associated with oculodentodigital dysplasia.
Kelly JJ; Esseltine JL; Shao Q; Jabs EW; Sampson J; Auranen M; Bai D; Laird DW
Mol Biol Cell; 2016 Jul; 27(14):2172-85. PubMed ID: 27226478
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic utility of histone H3.3 G34W, G34R, and G34V mutant-specific antibodies for giant cell tumors of bone.
Yamamoto H; Iwasaki T; Yamada Y; Matsumoto Y; Otsuka H; Yoshimoto M; Kohashi K; Taguchi K; Yokoyama R; Nakashima Y; Oda Y
Hum Pathol; 2018 Mar; 73():41-50. PubMed ID: 29241742
[TBL] [Abstract][Full Text] [Related]
25. ALCAM
Zhou Z; Li Y; Wang X; Hu J; Kuang M; Wang Z; Li S; Xu W; Xiao J
Cell Death Dis; 2018 Feb; 9(3):299. PubMed ID: 29463803
[TBL] [Abstract][Full Text] [Related]
26. Significance of Histone H3.3 (G34W)-Mutant Protein in Pathological Diagnosis of Giant Cell Tumor of Bone.
Miskad UA; Syamsul F; Dahlan H; Sungowati NK; Achmad D; Johan MP
Asian Pac J Cancer Prev; 2023 May; 24(5):1737-1741. PubMed ID: 37247296
[TBL] [Abstract][Full Text] [Related]
27. Connexin43 intercellular communication drives the early differentiation of human bone marrow stromal cells into osteoblasts.
Talbot J; Brion R; Lamora A; Mullard M; Morice S; Heymann D; Verrecchia F
J Cell Physiol; 2018 Feb; 233(2):946-957. PubMed ID: 28369869
[TBL] [Abstract][Full Text] [Related]
28. Up-regulation of BMP2/4 signaling increases both osteoblast-specific marker expression and bone marrow adipogenesis in Gja1Jrt/+ stromal cell cultures.
Zappitelli T; Chen F; Aubin JE
Mol Biol Cell; 2015 Mar; 26(5):832-42. PubMed ID: 25568340
[TBL] [Abstract][Full Text] [Related]
29. Loss of connexin43 expression in Ewing's sarcoma cells favors the development of the primary tumor and the associated bone osteolysis.
Talbot J; Brion R; Picarda G; Amiaud J; Chesneau J; Bougras G; Stresing V; Tirode F; Heymann D; Redini F; Verrecchia F
Biochim Biophys Acta; 2013 Apr; 1832(4):553-64. PubMed ID: 23313578
[TBL] [Abstract][Full Text] [Related]
30. Genomic instability in giant cell tumor of bone. A study of 52 cases using DNA ploidy, relocalization FISH, and array-CGH analysis.
Moskovszky L; Szuhai K; Krenács T; Hogendoorn PC; Szendroi M; Benassi MS; Kopper L; Füle T; Sápi Z
Genes Chromosomes Cancer; 2009 Jun; 48(6):468-79. PubMed ID: 19242928
[TBL] [Abstract][Full Text] [Related]
31. Giant cell tumor of bone: updated molecular pathogenesis and tumor biology.
Noh BJ; Park YK
Hum Pathol; 2018 Nov; 81():1-8. PubMed ID: 29944971
[TBL] [Abstract][Full Text] [Related]
32. Denosumab induces tumor reduction and bone formation in patients with giant-cell tumor of bone.
Branstetter DG; Nelson SD; Manivel JC; Blay JY; Chawla S; Thomas DM; Jun S; Jacobs I
Clin Cancer Res; 2012 Aug; 18(16):4415-24. PubMed ID: 22711702
[TBL] [Abstract][Full Text] [Related]
33. Expression of Matrix Metalloproteinase-9 and CD34 in Giant Cell Tumor of Bone.
Zhou X; Liu XZ; Fan GT; Wu SJ; Zhao JN; Shi X
Orthop Surg; 2016 May; 8(2):220-5. PubMed ID: 27384731
[TBL] [Abstract][Full Text] [Related]
34. Bortezomib Inhibits Giant Cell Tumor of Bone through Induction of Cell Apoptosis and Inhibition of Osteoclast Recruitment, Giant Cell Formation, and Bone Resorption.
Xu L; Luo J; Jin R; Yue Z; Sun P; Yang Z; Yang X; Wan W; Zhang J; Li S; Liu M; Xiao J
Mol Cancer Ther; 2016 May; 15(5):854-65. PubMed ID: 26861247
[TBL] [Abstract][Full Text] [Related]
35. Manipulating Cx43 expression triggers gene reprogramming events in dermal fibroblasts from oculodentodigital dysplasia patients.
Esseltine JL; Shao Q; Huang T; Kelly JJ; Sampson J; Laird DW
Biochem J; 2015 Nov; 472(1):55-69. PubMed ID: 26349540
[TBL] [Abstract][Full Text] [Related]
36. Cerebral ischemic injury is enhanced in a model of oculodentodigital dysplasia.
Kozoriz MG; Lai S; Vega JL; Sáez JC; Sin WC; Bechberger JF; Naus CC
Neuropharmacology; 2013 Dec; 75():549-56. PubMed ID: 23727526
[TBL] [Abstract][Full Text] [Related]
37. Anti-Histone H3.3 G34W antibody is a sensitive and highly specific immunohistochemistry marker for the diagnosis of Giant cell tumor of bone. A validation based on analysis of 198 cases from a single centre in India.
Kamble A; Hui M; Rao KN; Narayanan R; Reddy BR; Uppin SG; Chandrasekhar P
Indian J Pathol Microbiol; 2022; 65(3):617-629. PubMed ID: 35900490
[TBL] [Abstract][Full Text] [Related]
38. Characterization of gap junction proteins in the bladder of Cx43 mutant mouse models of oculodentodigital dysplasia.
Lorentz R; Shao Q; Huang T; Fishman GI; Laird DW
J Membr Biol; 2012 Jun; 245(5-6):345-55. PubMed ID: 22752022
[TBL] [Abstract][Full Text] [Related]
39. Expression profiles of miRNAs in giant cell tumor of bone showed miR-187-5p and miR-1323 can regulate biological functions through inhibiting FRS2.
Jin Y; Zhang J; Zhu H; Fan G; Zhou G
Cancer Med; 2020 May; 9(9):3163-3173. PubMed ID: 32154662
[TBL] [Abstract][Full Text] [Related]
40. Histone H3.3 mutation in giant cell tumor of bone: an update in pathology.
Yamamoto H; Ishihara S; Toda Y; Oda Y
Med Mol Morphol; 2020 Mar; 53(1):1-6. PubMed ID: 31748824
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
